Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry J Fry

Showing results (71-80 of 124) with videos related to

Pageof 13
Sort By:
Journal for Immunotherapy of Cancer|September 17, 2021
Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct designHaiying Qin, Lila Yang, John A Chukinas, et al.
Blood|November 2, 2002
IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primatesTerry J Fry, Marcin Moniuszko, Stephen Creekmore, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2007
Potential role for IL-7 in Fas-mediated T cell apoptosis during HIV infectionCaroline Fluur, Angelo De Milito, Terry J Fry, et al.
Leukemia|February 28, 2020
Serial evaluation of CD19 surface expression in pediatric B-cell malignancies following CD19-targeted therapyDiane Libert, Constance M Yuan, Katherine E Masih, et al.
Vaccine|April 16, 2014
A pan inhibitor of DASH family enzymes induces immunogenic modulation and sensitizes murine and human carcinoma cells to antigen-specific cytotoxic T lymphocyte killing: implications for combination therapy with cancer vaccinesRenee N Donahue, Brynn B Duncan, Terry J Fry, et al.
Radiology|March 3, 2009
Radiofrequency ablation induces antigen-presenting cell infiltration and amplification of weak tumor-induced immunitySergio A Dromi, Meghaan P Walsh, Sarah Herby, et al.
Frontiers in Immunology|September 7, 2021
Combining Immunocytokine and <i>Ex Vivo</i> Activated NK Cells as a Platform for Enhancing Graft-Versus-Tumor Effects Against GD2<sup>+</sup> Murine NeuroblastomaPaul D Bates, Alexander L Rakhmilevich, Monica M Cho, et al.
Blood Advances|August 8, 2019
Clonal expansion of CAR T cells harboring lentivector integration in the CBL gene following anti-CD22 CAR T-cell therapyNirali N Shah, Haiying Qin, Bonnie Yates, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 27, 2018
Systematic Evaluation of Neurotoxicity in Children and Young Adults Undergoing CD22 Chimeric Antigen Receptor T-Cell TherapyHaneen Shalabi, Pamela L Wolters, Staci Martin, et al.
Molecular Therapy. Advances|May 18, 2026
A single-cell multi-omics assay for simultaneous measurement of vector copy number and protein expression in CAR T cellsYilong Yang, Saurabh Parikh, Chieh-Yuan Li, et al.
Pageof 13

Showing results (71-80 of 124) with videos related to

Sort By:
Pageof 13
Journal for Immunotherapy of Cancer|September 17, 2021
Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct designHaiying Qin, Lila Yang, John A Chukinas, et al.
Blood|November 2, 2002
IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primatesTerry J Fry, Marcin Moniuszko, Stephen Creekmore, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2007
Potential role for IL-7 in Fas-mediated T cell apoptosis during HIV infectionCaroline Fluur, Angelo De Milito, Terry J Fry, et al.
Leukemia|February 28, 2020
Serial evaluation of CD19 surface expression in pediatric B-cell malignancies following CD19-targeted therapyDiane Libert, Constance M Yuan, Katherine E Masih, et al.
Vaccine|April 16, 2014
A pan inhibitor of DASH family enzymes induces immunogenic modulation and sensitizes murine and human carcinoma cells to antigen-specific cytotoxic T lymphocyte killing: implications for combination therapy with cancer vaccinesRenee N Donahue, Brynn B Duncan, Terry J Fry, et al.
Radiology|March 3, 2009
Radiofrequency ablation induces antigen-presenting cell infiltration and amplification of weak tumor-induced immunitySergio A Dromi, Meghaan P Walsh, Sarah Herby, et al.
Frontiers in Immunology|September 7, 2021
Combining Immunocytokine and <i>Ex Vivo</i> Activated NK Cells as a Platform for Enhancing Graft-Versus-Tumor Effects Against GD2<sup>+</sup> Murine NeuroblastomaPaul D Bates, Alexander L Rakhmilevich, Monica M Cho, et al.
Blood Advances|August 8, 2019
Clonal expansion of CAR T cells harboring lentivector integration in the CBL gene following anti-CD22 CAR T-cell therapyNirali N Shah, Haiying Qin, Bonnie Yates, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 27, 2018
Systematic Evaluation of Neurotoxicity in Children and Young Adults Undergoing CD22 Chimeric Antigen Receptor T-Cell TherapyHaneen Shalabi, Pamela L Wolters, Staci Martin, et al.
Molecular Therapy. Advances|May 18, 2026
A single-cell multi-omics assay for simultaneous measurement of vector copy number and protein expression in CAR T cellsYilong Yang, Saurabh Parikh, Chieh-Yuan Li, et al.
Pageof 13